Skip to main content
. 2020 Jul 9;160:105074. doi: 10.1016/j.phrs.2020.105074

Table 4.

The comparative analysis of quality standards for Scutellariae Radix in the standards of the mainstream pharmacopoeias, WHO and ISO.

Items ChP, 2015 JP, 17th KP, 11th EP, 9.0 USP-HMC WHO monograph ISO
Definition
Description
Identification Microscopic
TLC Reference crude drug; Baicalin; Baicalein; Wogonin Reference crude drug; Baicalin Reference crude drug Baicalin;
acteoside
Reference crude drug; Baicalin; Baicalein Baicalin
Loss on drying ≤10.0 % ≤12.0 % ≤15.0 % ≤12.0 % ≤12.0 % ≤12.0 % ≤15.0 %
Total ash ≤6.0 % ≤5.0 % ≤6.0 % ≤6.0 % ≤6.0 % ≤6.0 % ≤6.0 %
Acid-insoluble Ash ≤1.0 % ≤2.0 % ≤1.0 % ≤1.0 %
Ethanol-soluble extractives ≥40.0 % ≥24.0 % ≥18.0 % ≥15.0 % ≥26.0 %
Water-soluble extractives ≥28.0 % ≥40.0 %
Assay Baicalin: ≥9.0 % Baicalin: ≥10.0 % ≥10.0 % (total of Baicalin, baicalein and wogonin) Baicalin: ≥9.0 % ≥11.0 % (total of Baicalin and wogonin-7-O-glucuronide);
≥3.50 % (total of Baicalin and wogonin)
Baicalin: ≥9.0 % Baicalin: ≥8.0 %
Heavy metals
Pesticide residuals
Sulfur dioxide ≤ 150 ppm ≤ 30 ppm